Last updated on May 2020

Taltz in Combination With Enstilar for Psoriasis


Brief description of study

Enstilar in combination with Taltz for plaque psoriasis.

Detailed Study Description

A single center study of 25 subjects to assess the addition of Enstilar Foam in patients receiving Taltz for 24 weeks with BSA between 3% and 8%.

Clinical Study Identifier: NCT04372277

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.